-
1
-
-
31544469250
-
Treatment of hepatitis C-virus-related glomerulonephritis
-
Kamar N, Rostaing L, Alric L: Treatment of hepatitis C-virus-related glomerulonephritis. Kidney Int 69: 436-439, 2006
-
(2006)
Kidney Int
, vol.69
, pp. 436-439
-
-
Kamar, N.1
Rostaing, L.2
Alric, L.3
-
2
-
-
0041713942
-
The renin-angiotensin system and progression of renal disease: From hemodynamics to cell biology
-
Wolf G, Butzmann U, Wenzel UO: The renin-angiotensin system and progression of renal disease: From hemodynamics to cell biology. Nephron Physiol 93: P3-P13, 2003
-
(2003)
Nephron Physiol
, vol.93
-
-
Wolf, G.1
Butzmann, U.2
Wenzel, U.O.3
-
3
-
-
30044450372
-
Renal protective effects of the renin-angiotensin-aldosterone system blockade: From evidence-based approach to perspectives
-
Tylicki L, Larczynski W, Rutkowski B: Renal protective effects of the renin-angiotensin-aldosterone system blockade: from evidence-based approach to perspectives. Kidney Blood Press Res 28: 230-242, 2005
-
(2005)
Kidney Blood Press Res
, vol.28
, pp. 230-242
-
-
Tylicki, L.1
Larczynski, W.2
Rutkowski, B.3
-
4
-
-
0034937962
-
Renoprotective and anti-hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic (mRen-2)27 rat
-
Wilkinson-Berka JL, Gibbs NJ, Cooper ME, Skinner SL, Kelly DJ: Renoprotective and anti-hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic (mRen-2)27 rat. Nephrol Dial Transplant 16: 1343-1349, 2001
-
(2001)
Nephrol Dial Transplant
, vol.16
, pp. 1343-1349
-
-
Wilkinson-Berka, J.L.1
Gibbs, N.J.2
Cooper, M.E.3
Skinner, S.L.4
Kelly, D.J.5
-
5
-
-
33746520563
-
Combined AGE inhibition and ACEi decreases the progression of established diabetic nephropathy in B6 db/db mice
-
Zheng F, Zeng YJ, Plati AR, Elliot SJ, Berho M, Potier M, Striker LJ, Striker GE: Combined AGE inhibition and ACEi decreases the progression of established diabetic nephropathy in B6 db/db mice. Kidney Int 70: 507-514, 2006
-
(2006)
Kidney Int
, vol.70
, pp. 507-514
-
-
Zheng, F.1
Zeng, Y.J.2
Plati, A.R.3
Elliot, S.J.4
Berho, M.5
Potier, M.6
Striker, L.J.7
Striker, G.E.8
-
6
-
-
33947233679
-
Long-term, high-dosage candesartan suppresses inflammation and injury in chronic kidney disease: Nonhemodynamic renal protection
-
Yu C, Gong R, Rifai A, Tolbert EM, Dworkin LD: Long-term, high-dosage candesartan suppresses inflammation and injury in chronic kidney disease: Nonhemodynamic renal protection. J Am Soc Nephrol 18: 750-759, 2007
-
(2007)
J Am Soc Nephrol
, vol.18
, pp. 750-759
-
-
Yu, C.1
Gong, R.2
Rifai, A.3
Tolbert, E.M.4
Dworkin, L.D.5
-
7
-
-
33645308317
-
Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering
-
Izuhara Y, Nangaku M, Inagi R, Tominaga N, Aizawa T, Kurokawa K, van Ypersele de Strihou C, Miyata T: Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering. J Am Soc Nephrol 16: 3631-3641, 2005
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 3631-3641
-
-
Izuhara, Y.1
Nangaku, M.2
Inagi, R.3
Tominaga, N.4
Aizawa, T.5
Kurokawa, K.6
van Ypersele de Strihou, C.7
Miyata, T.8
-
8
-
-
33847203614
-
Effect of combining ACE inhibition with aldosterone blockade on proteinuria and renal damage in experimental nephrosis
-
Kramer AB, van der Meulen EF, Hamming I, van Goor H, Navis G: Effect of combining ACE inhibition with aldosterone blockade on proteinuria and renal damage in experimental nephrosis. Kidney Int 71: 417-424, 2007
-
(2007)
Kidney Int
, vol.71
, pp. 417-424
-
-
Kramer, A.B.1
van der Meulen, E.F.2
Hamming, I.3
van Goor, H.4
Navis, G.5
-
9
-
-
24344451692
-
Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1
-
Ma LJ, Nakamura S, Aldigier JC, Rossini M, Yang H, Liang X, Nakamura I, Marcantoni C, Fogo AB: Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1. J Am Soc Nephrol 16: 966-976, 2005
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 966-976
-
-
Ma, L.J.1
Nakamura, S.2
Aldigier, J.C.3
Rossini, M.4
Yang, H.5
Liang, X.6
Nakamura, I.7
Marcantoni, C.8
Fogo, A.B.9
-
10
-
-
0032988331
-
Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis
-
Nakamura T, Obata J, Kimura H, Ohno S, Yoshida Y, Kawachi H, Shimizu F: Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis. Kidney Int 55: 877-889, 1999
-
(1999)
Kidney Int
, vol.55
, pp. 877-889
-
-
Nakamura, T.1
Obata, J.2
Kimura, H.3
Ohno, S.4
Yoshida, Y.5
Kawachi, H.6
Shimizu, F.7
-
11
-
-
20144369870
-
Spironolactone in combination with cilazapril ameliorates proteinuria and renal interstitial fibrosis in rats with anti-Thy-1 irreversible nephritis
-
Asai M, Monkawa T, Marumo T, Fukuda S, Tsuji M, Yoshino J, Kawachi H, Shimizu F, Hayashi M, Saruta T: Spironolactone in combination with cilazapril ameliorates proteinuria and renal interstitial fibrosis in rats with anti-Thy-1 irreversible nephritis. Hypertens Res 27: 971-978, 2004
-
(2004)
Hypertens Res
, vol.27
, pp. 971-978
-
-
Asai, M.1
Monkawa, T.2
Marumo, T.3
Fukuda, S.4
Tsuji, M.5
Yoshino, J.6
Kawachi, H.7
Shimizu, F.8
Hayashi, M.9
Saruta, T.10
-
12
-
-
0343554049
-
Quinapril decreases renal endothelin-1 expression and synthesis in a normotensive model of immune-complex nephritis
-
Ruiz-Ortega M, Gomez-Garre D, Liu XH, Blanco J, Largo R, Egido J: Quinapril decreases renal endothelin-1 expression and synthesis in a normotensive model of immune-complex nephritis. J Am Soc Nephrol 8: 756-768, 1997
-
(1997)
J Am Soc Nephrol
, vol.8
, pp. 756-768
-
-
Ruiz-Ortega, M.1
Gomez-Garre, D.2
Liu, X.H.3
Blanco, J.4
Largo, R.5
Egido, J.6
-
13
-
-
0030877971
-
Effect of enalapril therapy on glomerular accumulation of immune complexes and mesangial matrix in experimental glomerulonephritis in the nonhuman primate
-
Hebert LA, Birmingham DJ, Mahan JD, Cosio FG, Dillon JJ, Sedmak DD, Shen XP, McAllister C: Effect of enalapril therapy on glomerular accumulation of immune complexes and mesangial matrix in experimental glomerulonephritis in the nonhuman primate. Am J Kidney Dis 30: 243-252, 1997
-
(1997)
Am J Kidney Dis
, vol.30
, pp. 243-252
-
-
Hebert, L.A.1
Birmingham, D.J.2
Mahan, J.D.3
Cosio, F.G.4
Dillon, J.J.5
Sedmak, D.D.6
Shen, X.P.7
McAllister, C.8
-
14
-
-
0037378445
-
The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL study
-
Keane WF, Brenner BM, de Zeeuw D, Grunfeld JP, McGill J, Mitch WE, Ribeiro AB, Shahinfar S, Simpson RL, Snapinn SM, Toto R: The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL study. Kidney Int 63: 1499-1507, 2003
-
(2003)
Kidney Int
, vol.63
, pp. 1499-1507
-
-
Keane, W.F.1
Brenner, B.M.2
de Zeeuw, D.3
Grunfeld, J.P.4
McGill, J.5
Mitch, W.E.6
Ribeiro, A.B.7
Shahinfar, S.8
Simpson, R.L.9
Snapinn, S.M.10
Toto, R.11
-
15
-
-
33750209033
-
Olmesartan reducing incidence of endstage renal disease in diabetic nephropathy trial (ORIENT): Rationale and study design
-
Imai E, Ito S, Haneda M, Chan JC, Makino H: Olmesartan reducing incidence of endstage renal disease in diabetic nephropathy trial (ORIENT): Rationale and study design. Hypertens Res 29: 703-709, 2006
-
(2006)
Hypertens Res
, vol.29
, pp. 703-709
-
-
Imai, E.1
Ito, S.2
Haneda, M.3
Chan, J.C.4
Makino, H.5
-
16
-
-
10744221480
-
Renoprotective effect of losartan in comparison to amlodipine in patients with chronic kidney disease and hypertension: A report of the Japanese Losartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) study
-
Iino Y, Hayashi M, Kawamura T, Shiigai T, Tomino Y, Yamada K, Kitajima T, Ideura T, Koyama A, Sugisaki T, Suzuki H, Umemura S, Kawaguchii Y, Uchida S, Kuwahara M, Yamazaki T: Renoprotective effect of losartan in comparison to amlodipine in patients with chronic kidney disease and hypertension: A report of the Japanese Losartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) study. Hypertens Res 27: 21-30, 2004
-
(2004)
Hypertens Res
, vol.27
, pp. 21-30
-
-
Iino, Y.1
Hayashi, M.2
Kawamura, T.3
Shiigai, T.4
Tomino, Y.5
Yamada, K.6
Kitajima, T.7
Ideura, T.8
Koyama, A.9
Sugisaki, T.10
Suzuki, H.11
Umemura, S.12
Kawaguchii, Y.13
Uchida, S.14
Kuwahara, M.15
Yamazaki, T.16
-
17
-
-
0037145856
-
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial
-
Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG: Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA 288: 2421-2431, 2002
-
(2002)
JAMA
, vol.288
, pp. 2421-2431
-
-
Wright Jr, J.T.1
Bakris, G.2
Greene, T.3
Agodoa, L.Y.4
Appel, L.J.5
Charleston, J.6
Cheek, D.7
Douglas-Baltimore, J.G.8
Gassman, J.9
Glassock, R.10
Hebert, L.11
Jamerson, K.12
Lewis, J.13
Phillips, R.A.14
Toto, R.D.15
Middleton, J.P.16
Rostand, S.G.17
-
18
-
-
0036951359
-
Remission of renal disease: Recounting the challenge, acquiring the goal
-
Brenner BM: Remission of renal disease: Recounting the challenge, acquiring the goal. J Clin Invest 110: 1753-1758, 2002
-
(2002)
J Clin Invest
, vol.110
, pp. 1753-1758
-
-
Brenner, B.M.1
-
19
-
-
0033620788
-
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic protein-uria
-
Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, Scolari F, Schena FP, Remuzzi G: Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic protein-uria. Lancet 354: 359-364, 1999
-
(1999)
Lancet
, vol.354
, pp. 359-364
-
-
Ruggenenti, P.1
Perna, A.2
Gherardi, G.3
Garini, G.4
Zoccali, C.5
Salvadori, M.6
Scolari, F.7
Schena, F.P.8
Remuzzi, G.9
-
20
-
-
85190687909
-
-
Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group Gruppo Italiano di Studi Epidemiologici in Nefrologia, Lancet 349: 1857-1863, 1997
-
Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet 349: 1857-1863, 1997
-
-
-
-
21
-
-
0035190760
-
Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice
-
Taneda S, Segerer S, Hudkins KL, Cui Y, Wen M, Segerer M, Wener MH, Khairallah CG, Farr AG, Alpers CE: Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice. Am J Pathol 159: 2355-2369, 2001
-
(2001)
Am J Pathol
, vol.159
, pp. 2355-2369
-
-
Taneda, S.1
Segerer, S.2
Hudkins, K.L.3
Cui, Y.4
Wen, M.5
Segerer, M.6
Wener, M.H.7
Khairallah, C.G.8
Farr, A.G.9
Alpers, C.E.10
-
22
-
-
85190708845
-
-
Astrakhan A, Omori M, Nguyen T, Becker-Herman S, Iseki M, Aye T, Hudkins K, Dooley J, Farr A, Alpers CE, Ziegler SF, Rawlings DJ: Local increase in thymic stromal lymphopoietin induces systemic alterations in B cell development [erratum appears in Nat Immunol 8: 780, 2007]. Nat Immunol 8: 522-531, 2007
-
Astrakhan A, Omori M, Nguyen T, Becker-Herman S, Iseki M, Aye T, Hudkins K, Dooley J, Farr A, Alpers CE, Ziegler SF, Rawlings DJ: Local increase in thymic stromal lymphopoietin induces systemic alterations in B cell development [erratum appears in Nat Immunol 8: 780, 2007]. Nat Immunol 8: 522-531, 2007
-
-
-
-
23
-
-
34247862443
-
Thymic stromal lymphopoietin transgenic mice develop cryoglobulinemia and hepatitis with similarities to human hepatitis C liver disease
-
Kowalewska J, Muhlfeld AS, Hudkins KL, Yeh MM, Farr AG, Ravetch JV, Alpers CE: Thymic stromal lymphopoietin transgenic mice develop cryoglobulinemia and hepatitis with similarities to human hepatitis C liver disease. Am J Pathol 170: 981-989, 2007
-
(2007)
Am J Pathol
, vol.170
, pp. 981-989
-
-
Kowalewska, J.1
Muhlfeld, A.S.2
Hudkins, K.L.3
Yeh, M.M.4
Farr, A.G.5
Ravetch, J.V.6
Alpers, C.E.7
-
24
-
-
33750741932
-
Renin-angiotensin-aldosterone system and progression of renal disease
-
Ruster C, Wolf G: Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol 17: 2985-2991, 2006
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 2985-2991
-
-
Ruster, C.1
Wolf, G.2
-
25
-
-
33845262861
-
Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway
-
Wolf G: Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway. Kidney Int 70: 1914-1919, 2006
-
(2006)
Kidney Int
, vol.70
, pp. 1914-1919
-
-
Wolf, G.1
-
26
-
-
1342343891
-
An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis
-
De Albuquerque DA, Saxena V, Adams DE, Boivin GP, Brunner HI, Witte DP, Singh RR: An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis. Kidney Int 65: 846-859, 2004
-
(2004)
Kidney Int
, vol.65
, pp. 846-859
-
-
De Albuquerque, D.A.1
Saxena, V.2
Adams, D.E.3
Boivin, G.P.4
Brunner, H.I.5
Witte, D.P.6
Singh, R.R.7
-
27
-
-
23044500474
-
ATR blockade reduces IFN-gamma production in lymphocytes in vivo and in vitro
-
Weidanz JA, Jacobson LM, Muehrer RJ, Djamali A, Hullett DA, Sprague J, Chiriva-Internati M, Wittman V, Thekkumkara TJ, Becker BN: ATR blockade reduces IFN-gamma production in lymphocytes in vivo and in vitro. Kidney Int 67: 2134-2142, 2005
-
(2005)
Kidney Int
, vol.67
, pp. 2134-2142
-
-
Weidanz, J.A.1
Jacobson, L.M.2
Muehrer, R.J.3
Djamali, A.4
Hullett, D.A.5
Sprague, J.6
Chiriva-Internati, M.7
Wittman, V.8
Thekkumkara, T.J.9
Becker, B.N.10
-
28
-
-
25844515028
-
Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice
-
Zhou B, Comeau MR, De Smedt T, Liggitt HD, Dahl ME, Lewis DB, Gyarmati D, Aye T, Campbell DJ, Ziegler SF: Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol 6: 1047-1053, 2005
-
(2005)
Nat Immunol
, vol.6
, pp. 1047-1053
-
-
Zhou, B.1
Comeau, M.R.2
De Smedt, T.3
Liggitt, H.D.4
Dahl, M.E.5
Lewis, D.B.6
Gyarmati, D.7
Aye, T.8
Campbell, D.J.9
Ziegler, S.F.10
-
29
-
-
0037246048
-
Growth factor expression in a murine model of cryoglobulinemia
-
Taneda S, Hudkins KL, Cui Y, Farr AG, Alpers CE, Segerer S: Growth factor expression in a murine model of cryoglobulinemia. Kidney Int 63: 576-590, 2003
-
(2003)
Kidney Int
, vol.63
, pp. 576-590
-
-
Taneda, S.1
Hudkins, K.L.2
Cui, Y.3
Farr, A.G.4
Alpers, C.E.5
Segerer, S.6
-
30
-
-
0042425687
-
Deletion of the fcgamma receptor IIb in thymic stromal lymphopoietin transgenic mice aggravates membranoproliferative glomerulonephritis
-
Muhlfeld AS, Segerer S, Hudkins K, Carling MD, Wen M, Farr AG, Ravetch JV, Alpers CE: Deletion of the fcgamma receptor IIb in thymic stromal lymphopoietin transgenic mice aggravates membranoproliferative glomerulonephritis. Am J Pathol 163: 1127-1136, 2003
-
(2003)
Am J Pathol
, vol.163
, pp. 1127-1136
-
-
Muhlfeld, A.S.1
Segerer, S.2
Hudkins, K.3
Carling, M.D.4
Wen, M.5
Farr, A.G.6
Ravetch, J.V.7
Alpers, C.E.8
-
31
-
-
0026076158
-
Mechanisms of clearance of immune complexes from peritubular capillaries in the rat
-
Alpers CE, Hudkins KL, Pritzl P, Johnson RJ: Mechanisms of clearance of immune complexes from peritubular capillaries in the rat. Am J Pathol 139: 855-867, 1991
-
(1991)
Am J Pathol
, vol.139
, pp. 855-867
-
-
Alpers, C.E.1
Hudkins, K.L.2
Pritzl, P.3
Johnson, R.J.4
|